Sarah E Abbott1, Fabian Camacho1, Lauren C Peres1, Anthony J Alberg2, Elisa V Bandera3, Melissa Bondy4, Michele L Cote5, Ellen Funkhouser6, Patricia G Moorman7, Edward S Peters8, Bo Qin3, Ann G Schwartz5, Jill Barnholtz-Sloan9, Paul Terry10, Joellen M Schildkraut11. 1. Department of Public Health Sciences, University of Virginia, PO Box 800765, Charlottesville, VA, 22903, USA. 2. Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia, SC, USA. 3. Department of Population Science, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. 4. Department of Medicine, Section of Epidemiology and Population Sciences, Baylor College of Medicine, Houston, TX, USA. 5. Department of Oncology and the Karmanos Cancer Institute Population Studies and Disparities Research Program, Wayne State University, Detroit, MI, USA. 6. Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. 7. Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA. 8. Epidemiology Program, Louisiana State University Health Sciences Center School of Public Health, New Orleans, LA, USA. 9. Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA. 10. Department of Medicine, University of Tennessee Medical Center-Knoxville, Knoxville, TN, USA. 11. Department of Public Health Sciences, University of Virginia, PO Box 800765, Charlottesville, VA, 22903, USA. jms2yf@virginia.edu.
Abstract
PURPOSE: While recreational physical activity (RPA) has been associated with reduced mortality in breast, colorectal, and prostate cancers, evidence for epithelial ovarian cancer (EOC) is limited. Most EOC studies have been in predominantly white populations, although inactivity is more prevalent and survival is poorer among African-American (AA) women. We examined RPA before and after EOC diagnosis and associations with survival among AA women. METHODS: We analyzed data from 264 EOC survivors enrolled in a population-based, case-control study who completed surveys that included questions about pre- and post-diagnosis RPA. Data were collected on RPA frequency, intensity, and duration before diagnosis and approximately 1 year after the baseline interview. We calculated metabolic equivalent of task (MET)-hours/week for pre- and post-diagnosis RPA, and evaluated associations with risk of mortality using Cox proportional hazards models. RESULTS: RPA before diagnosis was not associated with mortality. Hazard ratios (HRs) for post-diagnosis RPA were < 1.0 but not statistically significant after adjustment for covariates; HRs were 0.94 (95% CI 0.58, 1.54) for > 0-9 MET-hours/week and 0.53 (95% CI 0.21, 1.35) for > 9 MET-hours/week. CONCLUSIONS: Our results suggest that RPA may be inversely associated with mortality among AA women with ovarian cancer, although it is possible that the present study was underpowered to detect an association. There is a clear need for more studies of RPA after diagnosis in EOC survivors with attention to potential differences by race.
PURPOSE: While recreational physical activity (RPA) has been associated with reduced mortality in breast, colorectal, and prostate cancers, evidence for epithelial ovarian cancer (EOC) is limited. Most EOC studies have been in predominantly white populations, although inactivity is more prevalent and survival is poorer among African-American (AA) women. We examined RPA before and after EOC diagnosis and associations with survival among AA women. METHODS: We analyzed data from 264 EOC survivors enrolled in a population-based, case-control study who completed surveys that included questions about pre- and post-diagnosis RPA. Data were collected on RPA frequency, intensity, and duration before diagnosis and approximately 1 year after the baseline interview. We calculated metabolic equivalent of task (MET)-hours/week for pre- and post-diagnosis RPA, and evaluated associations with risk of mortality using Cox proportional hazards models. RESULTS: RPA before diagnosis was not associated with mortality. Hazard ratios (HRs) for post-diagnosis RPA were < 1.0 but not statistically significant after adjustment for covariates; HRs were 0.94 (95% CI 0.58, 1.54) for > 0-9 MET-hours/week and 0.53 (95% CI 0.21, 1.35) for > 9 MET-hours/week. CONCLUSIONS: Our results suggest that RPA may be inversely associated with mortality among AA women with ovarian cancer, although it is possible that the present study was underpowered to detect an association. There is a clear need for more studies of RPA after diagnosis in EOC survivors with attention to potential differences by race.
Entities:
Keywords:
African-American; Cancer survival; Ovarian cancer; Physical activity
Authors: Kathryn H Schmitz; Kerry S Courneya; Charles Matthews; Wendy Demark-Wahnefried; Daniel A Galvão; Bernardine M Pinto; Melinda L Irwin; Kathleen Y Wolin; Roanne J Segal; Alejandro Lucia; Carole M Schneider; Vivian E von Gruenigen; Anna L Schwartz Journal: Med Sci Sports Exerc Date: 2010-07 Impact factor: 5.411
Authors: Melinda L Irwin; Ashley Wilder Smith; Anne McTiernan; Rachel Ballard-Barbash; Kathy Cronin; Frank D Gilliland; Richard N Baumgartner; Kathy B Baumgartner; Leslie Bernstein Journal: J Clin Oncol Date: 2008-08-20 Impact factor: 44.544
Authors: Rachel Ballard-Barbash; Christine M Friedenreich; Kerry S Courneya; Sameer M Siddiqi; Anne McTiernan; Catherine M Alfano Journal: J Natl Cancer Inst Date: 2012-05-08 Impact factor: 13.506
Authors: Yang Zhou; Rowan Chlebowski; Michael J LaMonte; Jennifer W Bea; Lihong Qi; Robert Wallace; Sayeh Lavasani; Brian W Walsh; Garnet Anderson; Mara Vitolins; Gloria Sarto; Melinda L Irwin Journal: Gynecol Oncol Date: 2014-04 Impact factor: 5.304
Authors: Sarah E Abbott; Elisa V Bandera; Bo Qin; Lauren C Peres; Patricia G Moorman; Jill Barnholtz-Sloan; Ann G Schwartz; Ellen Funkhouser; Edward S Peters; Michele L Cote; Anthony J Alberg; Paul Terry; Melissa Bondy; Lisa E Paddock; Sydnee Crankshaw; Frances Wang; Fabian Camacho; Joellen M Schildkraut Journal: Cancer Med Date: 2016-02-29 Impact factor: 4.452
Authors: Rikki A Cannioto; Michael J LaMonte; Linda E Kelemen; Harvey A Risch; Kevin H Eng; Albina N Minlikeeva; Chi-Chen Hong; J Brian Szender; Lara Sucheston-Campbell; Janine M Joseph; Andrew Berchuck; Jenny Chang-Claude; Daniel W Cramer; Anna DeFazio; Brenda Diergaarde; Thilo Dörk; Jennifer A Doherty; Robert P Edwards; Brooke L Fridley; Grace Friel; Ellen L Goode; Marc T Goodman; Peter Hillemanns; Estrid Hogdall; Satoyo Hosono; Joseph L Kelley; Susanne K Kjaer; Rüdiger Klapdor; Keitaro Matsuo; Kunle Odunsi; Christina M Nagle; Catherine M Olsen; Lisa E Paddock; Celeste L Pearce; Malcolm C Pike; Mary A Rossing; Barbara Schmalfeldt; Brahm H Segal; Elizabeth A Szamreta; Pamela J Thompson; Chiu-Chen Tseng; Robert Vierkant; Joellen M Schildkraut; Nicolas Wentzensen; Kristine G Wicklund; Stacey J Winham; Anna H Wu; Francesmary Modugno; Roberta B Ness; Allan Jensen; Penelope M Webb; Kathryn Terry; Elisa V Bandera; Kirsten B Moysich Journal: Br J Cancer Date: 2016-06-14 Impact factor: 7.640
Authors: Roger T Anderson; Lauren C Peres; Fabian Camacho; Elisa V Bandera; Ellen Funkhouser; Patricia G Moorman; Lisa E Paddock; Edward S Peters; Sarah E Abbott; Anthony J Alberg; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ann G Schwartz; Paul Terry; Joellen M Schildkraut Journal: J Womens Health (Larchmt) Date: 2018-10-10 Impact factor: 2.681
Authors: Tianyi Wang; Mary K Townsend; A Heather Eliassen; Kathryn L Terry; Mingyang Song; Melinda L Irwin; Shelley S Tworoger Journal: Int J Cancer Date: 2021-05-21 Impact factor: 7.316
Authors: Sadia Mehdi; Elizabeth Macdonald; Kristianne Galpin; David A Landry; Galaxia Rodriguez; Barbara Vanderhyden; Dimcho Bachvarov Journal: Int J Mol Sci Date: 2020-07-15 Impact factor: 5.923